What to Know About This Fund’s $50 Million Exit From Ascendis Pharma
14/5 21:05
Key PointsSiren sold 235,862 shares of Ascendis Pharma in the first quarter; the estimated transaction value was $52.87 million based on quarterly average pricing....
|
|
|
14/5 21:05
Key PointsSiren sold 235,862 shares of Ascendis Pharma in the first quarter; the estimated transaction value was $52.87 million based on quarterly average pricing....